Reagan Jarvis

Company: Anocca

Job title: Chief Executive Officer & Co-Founder

Seminars:

Functional Enhancement of TCR from Suboptimal Frameworks 11:40 am

• Approach for TCR modification for heightened sensitivity and selectivity to targets • TCR selection and screening methodologies and parameters • Insights from off-target screening with modified TCR librariesRead more

day: Conference Day One

Functional Enhancement of TCR from Suboptimal Frameworks 1:30 pm

Approach for TCR modification for heightened sensitivity and selectivity to targets TCR selection and screening methodologies and parameters Insights from off-target screening with modified TCR librariesRead more

day: DAY ONE TRACK 2 A

Industry Leaders’ Fireside Chat: Unveiling the Future of T-Cell Receptor Therapies: What’s on the Horizon? 8:00 am

Uncovering the wealth of advancements in TCR therapy and analyzing data for robust clinical validation Exploring a spectrum of TCR modalities and their distinct targeting advantages Overcoming challenges with novel strategies and technologies, bringing us closer to a future where T-cell receptor therapies are not only groundbreaking but also widely accessibleRead more

day: Conference Day One